Skip to main content
Arrowhead Pharmaceuticals, Inc. (ARWR)
NASDAQ: ARWR · Real-Time Price · USD
13.82
+0.02 (0.14%)
Mar 28, 2025, 4:00 PM EDT - Market closed

Arrowhead Pharmaceuticals Revenue

Arrowhead Pharmaceuticals had revenue of $2.50M in the quarter ending December 31, 2024, a decrease of -29.60%. This brings the company's revenue in the last twelve months to $2.50M, down -98.62% year-over-year. In the fiscal year ending September 30, 2024, Arrowhead Pharmaceuticals had annual revenue of $3.55M, down -98.52%.

Revenue (ttm)
$2.50M
Revenue Growth
-98.62%
P/S Ratio
701.36
Revenue / Employee
$4,105
Employees
609
Market Cap
1.74B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20243.55M-237.18M-98.52%
Sep 30, 2023240.74M-2.50M-1.03%
Sep 30, 2022243.23M104.94M75.89%
Sep 30, 2021138.29M50.30M57.16%
Sep 30, 202087.99M-80.80M-47.87%
Sep 30, 2019 Pro Pro Pro
Sep 30, 2018 Pro Pro Pro
Sep 30, 2017 Pro Pro Pro
Sep 30, 2016 Pro Pro Pro
Sep 30, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

ARWR News

More News